Dr. Lerner is an expert in healthcare investing, with over over 20 years of in-depth experience in the areas of healthcare evaluation, investment research, finance and accounting. Dr. Lerner was the Founder and CEO of Rx Capital Management, a long-short healthcare equity hedge fund. Previously she was a Principal at Pequot Capital Management and a Managing Director in Equity Research at Lehman Brothers. At Rx Capital and Pequot Capital, Dr. Lerner managed investment funds of $700 million and $1.5 billion, respectively. While at Lehman Brothers, Dr Lerner achieved Institutional Investor Magazine “All Star” designation in biotechnology for 7 consecutive years. Dr. Lerner currently serves on the Board the Technology Transfer Advisory Committee of The Rockefeller University, where she earned her PhD. Dr. Lerner holds an MBA in Finance from New York University, a PhD in Molecular Biology from Rockefeller University, and a CFA charter from the Institute of Chartered Financial Analysts.